Results 181 to 190 of about 16,374 (258)

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Medical Care Insurance: Lessons from Voluntary and Compulsory Plans

American Journal of Public Health and the Nations Health, 1951
openaire   +6 more sources

Animal rabies prevention and control in Shanghai, China: policies and practices, 2011-2025. [PDF]

Front Public Health
Zhu T, Chang X, Wu X, Xia L, Zhu X, Zhu J, Li Z, Chen W, Fan Y, Tang Y, Liu J, Zhao H.   +11 more
europepmc   +1 more source

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

British Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang, Chen‐Han Chueh, Chien‐Yu Tseng, Christopher N. Kaufmann, Earl J. Morris, Chiao‐En Wu, Yi‐Wen Tsai   +6 more
wiley   +1 more source

No fault vaccine injury compensation after COVID-19: A systematic literature review and proposed typology. [PDF]

Hum Vaccin Immunother
Halabi S, Arora N, Durran A, Qian Q, Ummer S, Ginsbach K, Aneja K.   +6 more
europepmc   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

The association between obstetric comorbidity index and delivery hospitalization associated cost: a nationwide population study in Taiwan. [PDF]

BMC Health Serv Res
Huang WC, Cheng SH, Lin CC.
europepmc   +1 more source

Russian experience in healthcare quality assurance through standards of care: 2014-2023. [PDF]

BMJ Open Qual
Vlassov V, Gabuniya N, Vlasova A.
europepmc   +1 more source

ORGANIZATIONAL AND LEGAL MECHANISM OF INTRODUCTION OF COMPULSORY MEDICAL INSURANCE IN UKRAINE

Law Bulletin, 2020
openaire   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source